Video Buzz v1

RelatedLinks

October 29th

• The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.: Although DNA damaging agents have revolutionized chemotherapy against solid tumors, a narrow therape

September 25th

• The mTOR pathway 2008
• Image:MTOR-pat hway-betz.jpg - Wikipedia, the free encyclopedia

March 10th

• Sirolimus - Yahoo! Health: What is sirolimus? Sirolimus lowers your body's immune system. The immune system helps your body fight infections. The immune system can also fight or "reject&q uot; a transplanted organ such as a liver or kidney. This is because the immune system treats the ne
• Sirolimus - Wikipedia, the free encyclopedia: Sirolimus is a relatively new immunosuppress ant drug used to prevent rejection in organ transplantatio n, and is especially useful in kidney transplants. Sirolimus is a macrolide. It is marketed under the trade name Rapamune by Wyeth.
• Rapamune Consumer Information: What are some possible side effects of Rapamune? (This is not a complete list of side effects reported with Rapamune. Your health care provider can discuss with you a more complete list of side effects.) Rapamune is an immunosuppress ant drug. Immunosu
• MedlinePlus Drug Information: Sirolimus: Sirolimus is used in combination with other medications to prevent rejection of kidney transplants. Sirolimus is in a class of medications called immunosuppress ants. It works by suppressing the body's immune system.
• Sirolimus (Oral Route) - MayoClinic.com: US Brand Names * Rapamune Description Sirolimus belongs to a group of medicines known as immunosuppress ive agents. It is used to lower the body's natural immunity in patients who receive kidney transplants.

September 25th

• Safety and Efficacy of Sirolimus- and Paclitaxel-Elu ting Coronary Stents || NEJM 2007: Stone GW, Moses JW, Leon MB, Colombo A, Schampaert E, Grube E, et al.
• C-SIRIUS | Canadian study of the sirolimus-elut ing stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS): Schampaert E, Cohen EA, Popma JJ, et al.
• Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Uns ettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) | A: Drug-Eluting Stent Update 2007: Part III: Technique and Unapproved/Uns ettled Indications (Left Main, Bifurcations, Chronic Total Occlusions, Small Vessels and Long Lesions, Saphenous Vein Grafts, Acute Myocardial Infarctions, and Multivessel Disease) C

September 21st

• Las endoprótesis que liberan sirolimus superan a las de paclitaxel - DiarioMedico.c om

July 15th

• Meta-Analyses Find Increased Death and MI with Cypher Stent =|= CME Teaching Brief® =|= MedPage Today

July 11th

• ClinicalTrials .gov =|= ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial: Evaluation of Cypher Sirolimus Eluting Stent in Patients Undergoing Elective Revascularizat ion of Nonacute Total Coronary Occlusions (TCO). Cordis Corp. Columbia Presbyterian, NYC. 2006-2011. (Not currently recruiting)

RelatedImages

No Images Available!

Video Buzz > Sirolimus

Video Buzz Video Player :)

No Matching Video

No video for Sirolimus is available at this time.

Related Sirolimus News

Six Month Clinical Outcomes of SMT?s Supralimus-Sirolimus Eluting ... - Newswiretoday.com

NewswireToday - /newswire/ - Surat, Gujarat, India, 07/02/2009 - Six Month Clinical Outcomes of SMT?s Supralimus-Sirolimus Eluting Stent with a Biodegradable Polymer (part of the prospective Multicenter E-Series Registry) is presented at EuroPCR ...

Sirolimus Podcasts

Do you prefer to listen to your sirolimus gossip? Check out Podzy Podcast Directory > Sirolimus.

Sirolimus Products

Looking for sirolimus related products, then look no further. Try our new Sirolimus Shop.